HWKN Stock Analysis: Hawkins | NASDAQ

Water Treatment, Specialty Ingredients, Industrial Chemicals, Chemical Blending

Total Rating 52

Safety 80

Buy Signal -0.10

Specialty Chemicals
Industry Rotation: +0.6

Market Cap: 2.83B
Avg Turnover: 17.4M

Risk 3d forecast

Volatility67.2%

VaR 5^th Pctl11.1%

VaR vs Median0.19%

Reward TTM

Sharpe Ratio-0.13

Rel. Str. IBD40.5

Rel. Str. Peer Group59.4 pctl

Character TTM

Beta0.650

Beta Downside0.805

Hurst Exponent0.509

Choppyness72.5%

Drawdowns 3y

Max DD35.88%

CAGR/Max DD1.12

CAGR/Mean DD3.33

EPS (Earnings per Share)

EPS CAGR: 3.99%
EPS Trend: 64.5%

Last SUE: 1.24
Qual. Beats: 1

Revenue

Rev. CAGR: 8.83%
Rev. Trend: 98.0%

Last SUE: 1.10
Qual. Beats: 1

Warnings

Extended 1w

Below Avwap Earnings

Tailwinds

Squeeze

Ep Pivot

Seasonality 11.7 years of data

Jan -1.7% 11

Feb -0.9% 2

Mar +0.1% 7

Apr -0.1% 7

May -1.1% 15

Jun -0.4% 8

Jul +7.2% 21

Aug +0.4% 19

Sep -1.0% 5

Oct -3.8% 16

Nov +3.7% 11

Dec +4.1% 15

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: HWKN Hawkins

Hawkins, Inc. is a U.S.-based water treatment and specialty ingredients company operating through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment supplies chemicals, filtration systems, equipment, and services for potable water, wastewater, process water, pool water, and agricultural applications, including related tanks, valves, and pumps. The Food and Health Sciences segment provides ingredient distribution, processing, and formulation solutions - such as minerals, vitamins, botanicals, sweeteners, and pharmaceutical salts - to nutrition, food, pharma, and agricultural markets. The Industrial Solutions segment sells bulk and repackaged industrial chemicals, including caustic soda, sulfuric acid, and potassium hydroxide, to manufacturing, electronics, energy, and surface finishing industries, and performs custom chemical blending. The company also repackages bulk industrial and water treatment chemicals.

Founded in 1938 and headquartered in Roseville, Minnesota, Hawkins is listed on NASDAQ under the ticker HWKN. As a mid-cap stock in the GICS Materials sector (Commodity Chemicals sub-industry), it operates in the broadly fragmented U.S. specialty chemicals distribution market, where companies typically compete on technical service, logistics, and application expertise rather than commodity-scale production. Its three-segment structure spans defensive end markets municipal and industrial water, food and pharma ingredients, and general industrial chemicals - providing some diversification across cyclical and non-cyclical demand drivers.

Headlines to Watch Out For

Acquisitions drive specialty chemicals revenue growth across segments
Water Treatment segment benefits from municipal infrastructure spending
Industrial chemical margins pressured by raw material cost volatility

Piotroski VR-10 (Strict) 8.0

Net Income: 85.8m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 1.14 > 1.0
NWC/Revenue: 12.67% < 20% (prev 13.49%; Δ -0.82% < -1%)
CFO/TA 0.15 > 3% & CFO 148.8m > Net Income 85.8m
Net Debt (256.6m) to EBITDA (174.0m): 1.47 < 3
Current Ratio: 2.28 > 1.5 & < 3
Outstanding Shares: last quarter (20.8m) vs 12m ago -0.30% < -2%
Gross Margin: 22.44% > 18% (prev 22.69%; Δ -0.25% > 0.5%)
Asset Turnover: 114.2% > 50% (prev 106.2%; Δ 7.96% > 0%)
Interest Coverage Ratio: 10.27 > 6 (EBIT TTM 121.5m / Interest Expense TTM 11.8m)

Altman Z'' 5.28

A: 0.14 (Total Current Assets 257.1m - Total Current Liabilities 112.8m) / Total Assets 1.01b
B: 0.54 (Retained Earnings 548.0m / Total Assets 1.01b)
C: 0.12 (EBIT TTM 121.5m / Avg Total Assets 998.1m)
D: 1.68 (Book Value of Equity 563.7m / Total Liabilities 335.6m)
Altman-Z'' = 5.28 = AAA

Beneish M -3.24

DSRI: 1.04 (Receivables 149.3m/131.1m, Revenue 1.14b/1.05b)
GMI: 1.01 (GM 22.69% / 22.44%)
AQI: 0.46 (AQ_t 0.23 / AQ_t-1 0.49)
SGI: 1.09 (Revenue 1.14b / 1.05b)
TATA: -0.06 (NI 85.8m - CFO 148.8m) / TA 1.01b)
Beneish M = -3.24 (Cap -4..+1) = AA

What is the price of HWKN shares?

As of October 28, 2026, the stock is trading at USD 153.85 with a total of 423,452 shares traded. Over the past week, the price has changed by +17.45%, over one month by +20.36%, over three months by +9.76% and over the past year by -8.77%.

Current recommended Stop Loss: 149.00 (which is 3.2% or 1.3 ATR below the current price).

Is HWKN a buy, sell or hold?

Hawkins has received a consensus analysts rating of 3.67. Therefore, it is recommended to hold HWKN.

StrongBuy: 0
Buy: 2
Hold: 1
Sell: 0
StrongSell: 0

What are the forecasts/targets for the HWKN price?

Analysts Target Price	174	13.1%

Hawkins (HWKN) - Fundamental Data Overview as of 28 October 2026

Market Cap USD = 2.83b (2.83b USD * 1.0 USD.USD)
P/E Trailing = 35.0881
P/E Forward = 31.4465
P/S = 2.5561
P/B = 5.0379
P/EG = 2.6191
Revenue TTM = 1.14b USD
EBIT TTM = 121.5m USD
EBITDA TTM = 174.0m USD
Long Term Debt = 244.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 3.00m USD (from shortTermDebt, last fiscal year)
Debt = 263.7m USD (corrected: LT Debt 244.0m + ST Debt 3.00m) + Leases 16.7m
Net Debt = 256.6m USD (calculated: Debt 263.7m - CCE 7.10m)
Enterprise Value = 3.08b USD (2.83b + Debt 263.7m - CCE 7.10m)
Interest Coverage Ratio = 10.27 (Ebit TTM 121.5m / Interest Expense TTM 11.8m)
EV/FCF = 33.33x (Enterprise Value 3.08b / FCF TTM 92.5m)
FCF Yield = 3.00% (FCF TTM 92.5m / Enterprise Value 3.08b)
FCF Margin = 8.12% (FCF TTM 92.5m / Revenue TTM 1.14b)
Net Margin = 7.53% (Net Income TTM 85.8m / Revenue TTM 1.14b)
Gross Margin = 22.44% ((Revenue TTM 1.14b - Cost of Revenue TTM 883.8m) / Revenue TTM)
Gross Margin QoQ = 24.41% (prev 23.44%)
Tobins Q-Ratio = 3.05 (Enterprise Value 3.08b / Total Assets 1.01b)
Interest Expense / Debt = 4.48% (Interest Expense 11.8m / Debt 263.7m)
Taxrate = 6.06% (7.05m / 116.4m)
NOPAT = 114.1m (EBIT 121.5m * (1 - 6.06%))
Current Ratio = 2.28 (Total Current Assets 257.1m / Total Current Liabilities 112.8m)
Debt / Equity = 0.47 (Debt 263.7m / totalStockholderEquity, last quarter 563.7m)
Debt / EBITDA = 1.47 (Net Debt 256.6m / EBITDA 174.0m)
Debt / FCF = 2.77 (Net Debt 256.6m / FCF TTM 92.5m)
Total Stockholder Equity = 541.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.60% (Net Income 85.8m / Total Assets 1.01b)
RoE = 15.86% (Net Income TTM 85.8m / Total Stockholder Equity 541.2m)
RoCE = 15.47% (EBIT 121.5m / Capital Employed (Equity 541.2m + L.T.Debt 244.0m))
RoIC = 12.75% (NOPAT 114.1m / Invested Capital 895.2m)
WACC = 7.52% (E(2.83b)/V(3.09b) * Re(7.83%) + D(263.7m)/V(3.09b) * Rd(4.48%) * (1-Tc(0.06)))
Discount Rate = 7.83% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.95 | Cagr: -0.28%
[DCF] Terminal Value 77.97% ; FCFF base≈87.0m ; Y1≈99.8m ; Y5≈146.8m
[DCF] Fair Price = 93.55 (EV 2.21b - Net Debt 256.6m = Equity 1.95b / Shares 20.9m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 64.49 | EPS CAGR: 3.99% | SUE: 1.24 | # QB: 1
Revenue Correlation: 97.98 | Revenue CAGR: 8.83% | SUE: 1.10 | # QB: 1
EPS current Quarter (2026-12-31): EPS=0.73 | Chg30d=-5.56% | Revisions=-40% | Analysts=2
EPS current Year (2027-03-31): EPS=4.11 | Chg30d=-2.40% | Revisions=-40% | GrowthEPS=+4.0% | GrowthRev=+8.0%
EPS next Year (2028-03-31): EPS=4.68 | Chg30d=-2.43% | Revisions=-40% | GrowthEPS=+13.8% | GrowthRev=+7.5%
[Analyst] Revisions Ratio: -67% (up=0, down=6)